Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. (FOLD) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · FOLD · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
12
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Amicus Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
FOLD insider buying and selling by quarter
FOLD insider selling · FOLD insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · FOLD ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
FOLD executive sell shares · FOLD board member insider trading · FOLD insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Apr 27, 2026 | WHEELER CRAIG A Director | Other | 84,631 | $1.23M⚡ | Form 4 |
| Apr 27, 2026 | MCGLYNN MARGARET G Director | Other | 94,631 | $1.37M⚡ | Form 4 |
| Apr 27, 2026 | WHITMAN BURKE W Director | Other | 118,598 | $1.72M⚡ | Form 4 |
| Apr 27, 2026 | SBLENDORIO GLENN Director | Other | 142,564 | $2.07M⚡ | Form 4 |
| Apr 27, 2026 | ROBERTS EIRY Director | Other | 76,275 | $1.11M⚡ | Form 4 |
| Apr 27, 2026 | Bleil Lynn Dorsey Director | Other | 113,941 | $1.65M⚡ | Form 4 |
| Apr 27, 2026 | Kelly Michael Aaron Director | Other | 72,468 | $1.05M⚡ | Form 4 |
| Apr 27, 2026 | RAAB MICHAEL Director | Other | 115,857 | $1.68M⚡ | Form 4 |
| Apr 27, 2026 | Prout Samantha CAO | Other | 125,951 | $1.83M⚡ | Form 4 |
| Apr 27, 2026 | Castelli Jeff Chief Development Officer | Other | 427,089 | $6.19M⚡ | Form 4 |
| Apr 27, 2026 | Clark David Michael CPO | Other | 221,811 | $3.22M⚡ | Form 4 |
| Apr 27, 2026 | Rosenberg Ellen Chief Legal Officer | Other | 15,000 | $218K | Form 4 |
| Apr 27, 2026 | Harford Simon N.R. CFO | Other | 143,595 | $2.08M⚡ | Form 4 |
Kelly Michael Aaron
Director
Date
Apr 27
Shares
72,468
Price
$14.50
Value
$1.05M ⚡
Castelli Jeff
Chief Development Officer
Date
Apr 27
Shares
427,089
Price
$14.50
Value
$6.19M ⚡
Rosenberg Ellen
Chief Legal Officer
Date
Apr 27
Shares
15,000
Price
$14.50
Value
$218K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About FOLD insider trading
FOLD insider trades
Amicus Therapeutics, Inc. (FOLD) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including WHEELER CRAIG A (Director), MCGLYNN MARGARET G (Director), WHITMAN BURKE W (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. FOLD insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Amicus Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
FOLD insider trading · 5 questionsThe insiders of Amicus Therapeutics, Inc. (FOLD) include executives and directors such as WHEELER CRAIG A (Director), MCGLYNN MARGARET G (Director), WHITMAN BURKE W (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026